Aytekin Akyol

1.7k total citations
40 papers, 964 citations indexed

About

Aytekin Akyol is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Aytekin Akyol has authored 40 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Pathology and Forensic Medicine and 10 papers in Oncology. Recurrent topics in Aytekin Akyol's work include Genetic factors in colorectal cancer (8 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and Microtubule and mitosis dynamics (3 papers). Aytekin Akyol is often cited by papers focused on Genetic factors in colorectal cancer (8 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and Microtubule and mitosis dynamics (3 papers). Aytekin Akyol collaborates with scholars based in Türkiye, United States and Germany. Aytekin Akyol's co-authors include Eric R. Fearon, Kathleen R. Cho, Bart O. Williams, Takao Hinoi, Joel K. Greenson, Brian Theisen, David O. Ferguson, Rork Kuick, Yali Zhai and Rong Wu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Aytekin Akyol

37 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aytekin Akyol Türkiye 14 464 313 188 181 154 40 964
Liat Drucker Israel 20 537 1.2× 320 1.0× 75 0.4× 127 0.7× 119 0.8× 71 1.1k
Yuzhen Feng China 14 462 1.0× 230 0.7× 97 0.5× 81 0.4× 145 0.9× 30 827
Xiang‐Xi Xu United States 26 1.2k 2.6× 200 0.6× 216 1.1× 73 0.4× 247 1.6× 42 1.7k
Mélanie Mestdagt Belgium 11 568 1.2× 382 1.2× 118 0.6× 44 0.2× 141 0.9× 13 1.0k
Tzyvia Rye United Kingdom 17 271 0.6× 285 0.9× 565 3.0× 83 0.5× 139 0.9× 33 885
Caroline H. Diep United States 11 376 0.8× 574 1.8× 85 0.5× 40 0.2× 225 1.5× 15 1.1k
Alexander Gheldof Belgium 11 660 1.4× 437 1.4× 74 0.4× 54 0.3× 123 0.8× 26 1.1k
Masafumi Toyoshima Japan 18 494 1.1× 231 0.7× 260 1.4× 50 0.3× 47 0.3× 61 1.1k
Kerstin Enquist Sweden 15 476 1.0× 227 0.7× 47 0.3× 141 0.8× 117 0.8× 18 868
Kazuo Asanoma Japan 21 670 1.4× 235 0.8× 193 1.0× 35 0.2× 139 0.9× 59 1.3k

Countries citing papers authored by Aytekin Akyol

Since Specialization
Citations

This map shows the geographic impact of Aytekin Akyol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aytekin Akyol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aytekin Akyol more than expected).

Fields of papers citing papers by Aytekin Akyol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aytekin Akyol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aytekin Akyol. The network helps show where Aytekin Akyol may publish in the future.

Co-authorship network of co-authors of Aytekin Akyol

This figure shows the co-authorship network connecting the top 25 collaborators of Aytekin Akyol. A scholar is included among the top collaborators of Aytekin Akyol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aytekin Akyol. Aytekin Akyol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Akyol, Aytekin, et al.. (2024). Amine Oxidase, Copper Containing 3 (Aoc3) Knockout Mice Are More Prone to DSS-induced Colitis and Colonic Tumorigenesis. In Vivo. 38(5). 2300–2309. 1 indexed citations
3.
4.
Güner, Güneş, Deniz Can Güven, Aytekin Akyol, et al.. (2023). Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer. Clinics and Research in Hepatology and Gastroenterology. 47(7). 102171–102171. 11 indexed citations
5.
Saatci, Özge, Metin Çetįn, Ünal Metin Tokat, et al.. (2023). Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer. Nature Communications. 14(1). 6997–6997. 6 indexed citations
6.
Işık, Aynur, et al.. (2023). A Novel Gene List Identifies Tumors with a Stromal-Mesenchymal Phenotype and Worse Prognosis in Gastric Cancer. Cancers. 15(11). 3035–3035. 2 indexed citations
7.
Barrington, Sally F., Barbara Malene Fischer, Amy A. Kirkwood, et al.. (2023). BASELINE SUV AND EARLY RESPONSE, BUT NOT MTV, ARE ASSOCIATED WITH OUTCOME IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED WITH NIVOLUMAB IN THE CHECKMATE 205 TRIAL. Hematological Oncology. 41(S2). 92–93. 1 indexed citations
8.
Işık, Aynur, et al.. (2023). Role of Reduced Bdnf Expression in Novel Apc Mutant Allele-induced Intestinal and Colonic Tumorigenesis in Mice. In Vivo. 37(4). 1562–1575. 2 indexed citations
9.
Güven, Deniz Can, et al.. (2021). 456P Prognostic and predictive value of tumor-infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer. Annals of Oncology. 32. S561–S561. 2 indexed citations
10.
Işık, Aynur, Arzu Sağlam, Gökhan Gedikoğlu, et al.. (2021). Loss of CTNNB1 exon 3 in sclerosing angiomatoid nodular transformation of the spleen. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(4). 747–754. 9 indexed citations
11.
Şimşek, Cem, et al.. (2021). Comprehensive clinicopathologic characteristics of intraabdominal neurogenic tumors: Single institution experience. World Journal of Clinical Cases. 9(10). 2218–2227. 3 indexed citations
12.
Akbulut, Özge, Özge Saatci, Urartu Özgür Şafak Şeker, et al.. (2020). A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate. Molecular Cancer Therapeutics. 19(6). 1243–1254. 21 indexed citations
13.
Işık, Aynur, Güneş Güner, Hakan Gürdal, et al.. (2019). Class III β-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response. Anticancer Research. 39(2). 655–662. 14 indexed citations
14.
Tamer, Funda, et al.. (2019). The potential efficacy of dietary fatty acids and fructose induced inflammation and oxidative stress on the insulin signaling and fat accumulation in mice. Food and Chemical Toxicology. 135. 110914–110914. 37 indexed citations
15.
Saatci, Özge, Simone Borgoni, Özge Akbulut, et al.. (2018). Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer. Oncogene. 37(17). 2251–2269. 66 indexed citations
16.
Akyol, Aytekin, Güneş Güner, Aynur Işık, et al.. (2018). An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues. Laboratory Investigation. 99(1). 128–137. 18 indexed citations
17.
Feng, Ying, Naoya Sakamoto, Rong Wu, et al.. (2015). Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium. PLoS Genetics. 11(11). e1005638–e1005638. 17 indexed citations
18.
Takakura, Yuji, Takao Hinoi, Naohide Oue, et al.. (2010). CDX2 Regulates Multidrug Resistance 1 Gene Expression in Malignant Intestinal Epithelium. Cancer Research. 70(17). 6767–6778. 34 indexed citations
19.
Akyol, Aytekin, et al.. (2008). Generating somatic mosaicism with a Cre recombinase–microsatellite sequence transgene. Nature Methods. 5(3). 231–233. 35 indexed citations
20.
Wu, Rong, Rork Kuick, Yali Zhai, et al.. (2007). Mouse Model of Human Ovarian Endometrioid Adenocarcinoma Based on Somatic Defects in the Wnt/β-Catenin and PI3K/Pten Signaling Pathways. Cancer Cell. 11(4). 321–333. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026